Skip to main content

Advertisement

SpringerLink
Log in

A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Perrotti D, Jamieson C, Goldman J, Skorski T . Chronic myeloid leukemia: mechanisms of blastic transformation. J Clin Invest 2010; 120: 2254–2264.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Calabretta B, Perrotti D . The biology of CML blast crisis. Blood 2004; 103: 4010–4022.

    Article  CAS  PubMed  Google Scholar 

  3. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. Myeloproliferative neoplasms. WHO Classification of Tumours of Haematopoietic and Lympoid Tissues. IARC: Lyon, France, 2008.

    Google Scholar 

  4. Burke BA, Carroll M . BCR-ABL: a multi-faceted promoter of DNA mutation in chronic myelogeneous leukemia. Leukemia 2010; 24: 1105–1112.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Zhang S . The role of aberrant transcription factor in the progression of chronic myeloid leukemia. Leuk Lymphoma 2008; 49: 1463–1469.

    Article  PubMed  Google Scholar 

  6. Iacobucci I, Storlazzi CT, Cilloni D, Lonetti A, Ottaviani E, Soverini S et al. Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP). Blood 2009; 114: 2159–2167.

    Article  CAS  PubMed  Google Scholar 

  7. Abdel-Wahab O, Kilpivaara O, Patel J, Busque L, Levine RL . The most commonly reported variant in ASXL1 (c.1934dupG; p.Gly646TrpfsX12) is not a somatic alteration. Leukemia 2010; 24: 1656–1657.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Miething C, Grundler R, Mugler C, Brero S, Hoepfl J, Geigl J et al. Retroviral insertional mutagenesis identifies RUNX genes involved in chronic myeloid leukemia disease persistence under imatinib treatment. Proc Natl Acad Sci USA 2007; 104: 4594–4599.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MLL Munich Leukemia Laboratory, Munich, Germany

    V Grossmann, A Kohlmann, M Zenger, S Schindela, C Eder, S Weissmann, S Schnittger, W Kern, T Haferlach & C Haferlach

  2. III. Medizinische Klinik, Universitätsmedizin Mannheim, Mannheim, Germany

    M C Müller

  3. Abteilung Hämatologie und Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany

    A Hochhaus

Authors
  1. V Grossmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Kohlmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Zenger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S Schindela
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C Eder
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Weissmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S Schnittger
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. W Kern
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M C Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. A Hochhaus
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. T Haferlach
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. C Haferlach
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V Grossmann.

Ethics declarations

Competing interests

CH, S Schnittger, WK, and TH have equity ownership of MLL Munich Leukemia Laboratory. VG, AK, MZ, CE, S Schindela, and SW are employed by MLL Munich Leukemia Laboratory. MCM and AH declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Leukemia website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grossmann, V., Kohlmann, A., Zenger, M. et al. A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases. Leukemia 25, 557–560 (2011). https://doi.org/10.1038/leu.2010.298

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2010.298

  • Springer Nature Limited

This article is cited by

Search

Navigation